Dickinson Jonathan Elliott

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)11%10%0%0%
Sale Success Rate0 of 21 of 21 of 20 of 20 of 2

Incyte Corp

Drugs » Biotechnology

EVP, General Manager, Europe:

Holdings: 36.39K shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--